Dihydropyrimidine dehydrogenase catalyzes the first and rate-limiting react
ion in pyrimidine catabolism. The enzyme contains one FMN, one FAD and four
Fe-S clusters per subunit of 1025 amino acids as prosthetic groups. It is
also the major determinant of bioavailability and toxicity of 5-fluorouraci
l, a chemotherapeutic agent widely used in the treatment of solid tumors. C
rystals of this enzyme diffracting to at least 2.5 Angstrom have been obtai
ned by the hanging-drop vapour-diffusion method and belong to space group P
2(1) (unit-cell parameters a = 82.0, b = 159.3, c = 163.6 Angstrom, beta =
96.1 degrees), with two homodimers per asymmetric unit.